Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

People with chronic Alopecia Areata often have lower vitamin D levels.

Low-dose oral minoxidil effectively treats female hair loss with good safety.

Early and aggressive treatment can significantly regrow hair in discoid lupus erythematosus.

Low-dose oral minoxidil helped regrow eyebrows in women with Frontal Fibrosing Alopecia.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Oxidative stress plays a role in female pattern baldness, causing an imbalance between harmful and protective elements in the body.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Oral dutasteride improves hair growth, reduces hair loss, and is safe for most patients.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

The document concludes that changing the scalp's microbiome might be a new way to treat hair loss.

New shampoo with tyramine hydrochloride reduces hair loss by making a small muscle in the hair follicle contract.

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

Enzyme booster SULT1A1 greatly enhances hair regrowth with minoxidil.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Men with hair loss feel it affects their emotions and life quality, and want more effective treatments.

COVID-19 can cause hair loss, but specialists can help treat it.

The microbiome may be linked to hair loss and could be a target for new treatments.

The report concludes that atypical Brauer nevus is more common in males, present at birth, and often misdiagnosed due to its unusual scalp locations.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.

The normal range for the hair pull test is 2 hairs or fewer, and washing or brushing hair before the test does not affect the results.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.